ResMed Aktie
230,90
EUR
-3,30
EUR
-1,41
%
273,60
USD
-1,67
USD
-0,61
%
Werbung
ResMed Aktie Analyse
25.09.17 | ResMed Underweight | Barclays Capital | |
07.04.16 | ResMed Underweight | Barclays Capital | |
27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung